KE
Karin Eastham (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $872K of VCYT (19,200 sh across 2 lots, as filed), executed Dec 5 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.8M
shares × price, as filed
Last traded
Oct 27
Filed Oct 28
Median ADV $55.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
VCYTRecent filings
VCYTSALE
Veracyte, Inc.
View filing →
$743K14,850 sh × $50.00
Exec Oct 27
Filed Oct 28 · 4:05 PM ET VCYTSALE Veracyte, Inc. View filing → $169K
3,200 sh × $52.78
Exec Jun 18
Filed Jun 22 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $872K
19,200 sh across 2 lots
Exec Dec 5 2025
Filed Dec 8 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $387K
9,674 sh × $40.02
Exec Nov 5 2025
Filed Nov 7 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $122K
4,590 sh × $26.66
Exec Jun 13 2025
Filed Jun 17 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $403K
10,000 sh across 2 lots
Exec Jan 2 2025
Filed Jan 6 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $506K
13,131 sh across 2 lots
Exec Nov 19 2024
Filed Nov 21 2024 · 5:30 PM ET